NEW YORK (GenomeWeb News) – Amyris said today that it has received a contract from the US Department of Defense Advanced Research Projects Agency that could total around $8 million to expand the scope of its synthetic biology technology across new biological platforms and cell types.

DARPA awarded the contract in connection with its Living Foundries Program, which seeks to create the fundamental production methods and tools, technologies, and methods required to make bio-engineering better, faster, and more accurate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.